초록 ▼

This invention pertains to the discovery that the human NELL-1 gene induces or upregulates bone mineralization. The NELL-1 gene or gene product thus provides a convenient target for screening for modulators of bone mineralization. In addition, NELL-1 can be used to facilitate repair of bone fracture

This invention pertains to the discovery that the human NELL-1 gene induces or upregulates bone mineralization. The NELL-1 gene or gene product thus provides a convenient target for screening for modulators of bone mineralization. In addition, NELL-1 can be used to facilitate repair of bone fractures and/or to generally increase bone density.

대표청구항 ▼

What is claimed is: 1. A bone graft material capable of enhancing the formation of osseous tissue in the animal in which it is implanted comprising a biocompatible matrix and a NELL-1 protein in an amount effective for stimulating a progenitor cell such that it is activated to differentiate into an

What is claimed is: 1. A bone graft material capable of enhancing the formation of osseous tissue in the animal in which it is implanted comprising a biocompatible matrix and a NELL-1 protein in an amount effective for stimulating a progenitor cell such that it is activated to differentiate into an osteoblast wherein the NELL-1 protein is selected from NELL-1 proteins encoded by SEQ ID NO. 1 and SEQ ID NO.2. 2. The bone graft material of 1, wherein the biocompatible matrix is resorbable. 3. The bone graft material of claim 1, wherein the biocompatible matrix comprises a resorbable polymer. 4. The bone graft material of claim 1, wherein the NELL-1 protein is produced by a cell within the matrix expressing exogenous NELL-1 protein. 5. The bone graft material of claim 1, wherein the biocompatible matrix comprises a cell adhesion molecule. 6. The bone graft material of claim 1, wherein the biocompatible matrix comprises a bioglass. 7. The bone graft material of claim 1, wherein the biocompatible matrix comprises a bioceramics. 8. The bone graft material of claim 1, wherein the biocompatible matrix comprises a collagen. 9. The bone graft material of claim 1, wherein the biocompatible matrix comprises a collagen in an amount ranging from about 65 to about 95 weight percent of the total bone graft material. 10. The bone graft material of claim 1, further comprising a bone morphogenic protein.